PX-866

PX-866 · Cascadian Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for PX-866, covering 2018-05-16 to 2020-05-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer [Phase 2]

See pricing